79results about How to "Increased cost of treatment" patented technology

Methods of processing a fluid recovered from an oil or gas extraction operation for reuse in a hydraulic fracturing fluid are described. The methods include providing an amount of a produced fluid composition containing iron and suspended solids and controlling at least one of the conductivity, iron content, oxidative strength, and pH of the composition, such that Fenton's reagent is formed in situ. Also described are hydraulic fracturing fluids produced using fluid recovered from an oil or gas production process and treated in accordance with the methods described herein as well as systems for preparing a hydraulic fracturing fluid having, as a fluid source, fluid recovered from an oil or gas production process that has been treated in accordance with the methods described herein.

The invention relates to a method and device for treating or preventing or suppressing a disease or condition in a non-human animal. The method comprises the steps of providing a single delivery device containing two components for sequential delivery from the delivery device. A first component is delivered from the single delivery device into a teat canal of a non-human animal and subsequently the second component is delivered from the single delivery device into the teat canal. The components are delivered without substantial mixing of the components.

A substrate treatment apparatus is provided with a treatment bath (1) composed of a bottomed container which is surrounded by side walls (2b-2e) on the four sides and is open at the top, and first and second supplying nozzle tubes (10a-10d) which supply the treatment bath (1) with a treatment solution. The first and second supplying nozzle tubes (10a-10d) are composed of supplying nozzle tubes having a plurality of jetting ports (11) arranged on one line at prescribed intervals on each side plane in a longitudinal direction of the hollow tube-shaped body. The jetting ports of the first supplying nozzle tubes (10b, 10d) among the nozzle tubes are inclined diagonally downward at a prescribed angle from the horizontal direction, the jetting ports of the second supplying nozzle tubes (10a, 10c) are inclined diagonally upward at a prescribed angle from the horizontal direction, and the supplying nozzle tubes are arranged substantially horizontal at prescribed intervals on one side wall plane (2b) of the treatment bath (1). Stagnation of the treatment solution in the treatment bath is eliminated, uniform substrate treatment is made possible and furthermore, particle removal is facilitated.

The invention belongs to the filed of medicine and discloses a pharmaceutical composition using fimasartan and rosuvastatin or medicinal salt thereof as active components, wherein a mass ratio of rosuvastatin or medicinal salt thereof to fimasartan is 1:0.25-250 and preferably 1:10-100. The pharmaceutical composition containing rosuvastatin medicinal salt thereof and fimasartan has obvious synergism on treating hypertension and complications thereof, low treatment cost, little side-effect and good clinic application prospect.

The present invention relates to one composition for preventing and treating cardiac and cerebral vascular diseases and the composition may be used as medicine, health food or health food additive. The composition consists of red yeast and haw or haw leaf, and may contain gingko leaf and lotus leaf. The composition is used in preventing and treating hypertension, hyperlipemia, etc causing cardiac and cerebral vascular diseases, and has determined curative effect and no toxic side effect.

The present invention belongs to the field of screening antituberculotic target, vaccine antigen and detecting target in molecular biological technology, and is especially process of screening protein resisting rifampicin as antituberculotic. The process includes the first culturing drug resistant strain, the subsequent separating protein of drug resistant strain from protein of sensitive strain, comparing protein of drug resistant strain and protein of sensitive strain to determine the drug resistant protein, and final separating and identifying drug resistant protein. The process of the present invention can separate and identify drug resistant protein of Mycobacterium tuberculosis to provide new way for further understanding the drug resisting mechanism of Mycobacterium tuberculosis, fast clinical detection of drug resistant strain, and developing vaccine and medicine.

The invention discloses a pharmaceutical composition for treating a heart failure with preserved ejection fraction. The pharmaceutical composition comprises two active components: (1) activity factors of mitochondria acetaldehyde dehydrogenase 2 enzymatic activity; and (2) a nitrate medicine. According to the pharmaceutical composition, left ventricular end diastolic pressure is effectively reduced; the symptom of myocardial hypertrophy of a heart failure patient is improved; the heart failure with preserved ejection fraction is treated; meanwhile, the tolerance of the nitrate medicine when the heart failure with preserved ejection fraction is effectively reduced; and the effective dose of each single medicine is reduced, so that the incidence rate of the side effect of the medicine is relatively low; the treatment cost is also reduced; the benefit/cost ratio of treatment is obviously improved; the compliance of a patient is increased; the living quality is obviously improved.

The invention provides a discharge gas treatment apparatus and method which prevent increase in treatment cost and which attain efficient removal of mercury contained in a discharge gas. The discharge gas treatment apparatus, for treating a discharge gas containing nitrogen oxide, sulfur oxide, metallic mercury, and hydrogen chloride, includes a cooling apparatus for controlling the temperature of the discharge gas to a predetermined temperature in accordance with the hydrogen chloride concentration of the discharge gas; an NO_x removal catalyst unit for reducing nitrogen oxide contained in the discharge gas for removal thereof and for causing reaction between mercury and hydrogen chloride contained in the discharge gas to thereby form mercury chloride, the discharge gas having been controlled to the predetermined temperature and having been introduced to the apparatus, with ammonia being added thereto; and a wet-format desulfurization apparatus, disposed on the downstream side with respect to the NO_x removal catalyst unit, for removing sulfur oxide and mercury chloride contained in the discharge gas through dissolving sulfur oxide and mercury chloride in a liquid absorbent. The apparatus has a simple structure and prevents an increase in treatment cost.

The invention relates to a method and device for treating or preventing or suppressing a disease or condition in a non-human animal. The method comprises the steps of providing a single delivery device containing two components for sequential delivery from the delivery device. A first component is delivered from the single delivery device into a teat canal of a non-human animal and subsequently the second component is delivered from the single delivery device into the teat canal. The components are delivered without substantial mixing of the components.

The invention provides an anti-alopecia hair-growing hair-blacking and hair-nourishing liquid and a manufacture method, and belongs to the technical field of traditional Chinese medicines. The anti-alopecia hair-growing hair-blacking and hair-nourishing liquid is prepared from the following raw materials in parts by weight: 10-15 parts of radix polygoni multiflori praeparata, 10-15 parts of cacumen platycladi, 5-10 parts of rhizoma zingiberis recens, 4-8 parts of herba ecliptae, 4-8 parts of fructus ligustri lucidi, 4-8 parts of radix rehmanniae praeparata, 4-8 parts of mori fructus, 4-8 partsof ginseng radix, 4-8 parts of rhizoma gastrodiae, 4-8 parts of radix astragali, 4-8 parts of radix angelicae sinensis, 4-8 parts of rhizoma chuanxiong, 4-8 parts of stigma croci, 4-8 parts of cortexdictamni, 4-8 parts of herba portulacae and 4-8 parts of rubiae radix. Ethyl alcohol and water are taken as solvents, the anti-alopecia hair-growing hair-blacking and hair-nourishing liquid is manufactured by a cold leaching method and has an obvious curative effect on symptoms, including alopecia, leukotrichia and the like caused by various reasons, and after the anti-alopecia hair-growing hair-blacking and hair-nourishing liquid is used for a long time, the hair is black and beautiful and is full of resilience. The anti-alopecia hair-growing hair-blacking and hair-nourishing liquid has a simple manufacture technology and a low cost, is quick to take effects, does not contain hormones or chemical ingredients, does not have toxic or side effects and has a wide applicable range.

A transcranial magnetic stimulation (TMS) coil positioning device includes a stimulation coil (1), a coil position tracking module (2), a head fixing frame (3), a head position tracking module (4), athree-dimensional mobile seat (5), a camera (6), a coil rotating device (7), a control system (8), an image processing module (9), an electromagnetic field calculation module (10), and a display (11).The image processing module (9) reconstructs the three-dimensional head model of a patient in an image space. The electromagnetic field calculation module (10) obtains the optimal coil position and angle by inversion according to the position of a nerve fiber to be activated in a target treatment target area. The control system (8), by means of the camera (6), the coil position tracking module (2), the coil rotating device (7), the head position tracking module (4), the head fixing frame (3) and the three-dimensional mobile seat (5), adjusts the relative position and angle of the stimulationcoil (1) and a patient head (12) to a target position and a target angle.

The invention relates to application of an artemisia leaf extract, and in particular relates to application of an artemisia leaf extract in a medicament for treating pulmonary heart diseases and a preparation method of the artemisia leaf extract. The invention discloses the application of the artemisia leaf extract in preparing the medicament for treating the pulmonary heart diseases. The pulmonary heart diseases have the characteristics of high epidemicity, high morbidity rate, high death rate and high cost, and surveys show that the morbidity rate of people living in rural areas in northern China is 0.44%, therefore, the development of a pulmonary heart disease Chinese traditional medicine treatment medicament with a definite curative effect, a reasonable cost and sufficient supply of goods is of great significance. Meanwhile, the traditional Chinese medicament namely artemisia leaf is further developed and studied, and is finally pushed to the market, which also is one of important paths of realizing modernization of Chinese medicaments.

The invention belongs to the technical field of medicine healthcare and particularly relates to a compound essential oil for adjutant therapy of burns and scalds. The compound essential oil for adjutant therapy of burns and scalds is mainly prepared from the following components in percentage by weight: 80-95% of mealworm oil, 1-3% of thyme essential oil, 0.5-1% of clove essential oil, 1-2% of chamomile essential oil and 5-15% of grape seed oil. The invention aims to solve the problems of slowness for wound healing, easiness for infection, high treatment expense and scars remained after healing, which are caused by the fact that the burns and the scalds are mainly treated by using drugs at present.

The invention discloses an oral pharmaceutical composition for treating or preventing obesity-related hypertension and its application and belongs to the field of medicine. The pharmaceutical composition comprises orlistat and lol-suffixed pharmaceutical active ingredients. The usage of orlistat and lol-suffixed pharmaceuticals in the pharmaceutical composition is greatly reduced, thus the risk of pharmaceuticals injuring the human body is reduced. The oral pharmaceutical composition has significant synergistic effect in treating or preventing obesity-related hypertension, can reduce the weight of a patient and the risk of hypertension being complicated by cardiovascular diseases and has higher social value.

The present invention discloses a medicine combination for remedying the arthralgia due to rheumatism. The combination consists of white mustard seed, galangal, long pepper, red peony root, garden balsam seed, pricklyash peel, cassia twig, dried ginger, gamboges, nux vomica, pseudo ginseng root, os draconis, asarum, cinnamon, clove, dragon blood and dahurian angelica root. The medicine combination of the present invention can promote blood circulation for dissolving stasis to eliminate damaged tissue swelling, so as to ensure that intervertebral disc fibrous ring shrinks to recover automatically; the pressure of nerve root is released to dissolve pain and restore destroyed fibre, which not only can avoid the pain caused by operation and the large amount of treatment expense, but also the treatment time is short, and recrudesce and rebound can not occur.

The invention discloses a dedicated primer for auxiliarily detecting a NDM-1 (New Metallo-Beta-Lactamase-1) gene and application thereof. The dedicated primer for auxiliarily detecting the NDM-1 (New Metallo-Beta-Lactamase-1) gene, provided by the invention, consists of DNA (deoxyribonucleic acids) shown by a sequence 1, a sequence 2, a sequence 3, a sequence 4, a sequence 5 and a sequence 6 in asequence table; and the NDM-1 protein is protein consisting of amino acid sequences shown in a sequence 7. The dedicated primer has the characteristics of high sensitivity, high speed, strong specificity, simpleness and convenience, safety, and the like while used for detection, can be widely applied to improve the pathogenic microorganism detection capability of a low apparatus location area, and has great significance for early and accurate diagnosis of pathogenic microorganisms. The dedicated primer can not only be used for guiding clinical reasonable medication and avoiding from delaying illness and increasing treatment expenses, but also is beneficial to controlling propagation of the pathogenic microorganisms and preventing outbreak, thereby having important significance for improving the treatment effect and controlling infection in hospitals.

Compounds, compositions, methods, and uses are described herein for the treatment of respiratory diseases, including cystic fibrosis. Inhalation formulations of macrolide antibiotics are also described herein. The treatment of bacterial infections continues to be an important endeavor of pharmaceutical research and development. The specter of bacterial resistance to currently available antibiotics is ever-present, and accordingly, new and improved compounds, pharmaceuticals formulations, treatment methods, and treatment protocols are needed.